Vifor Confident About Veltassa Despite AZ Rival

Hyperkalemia Therapy Now Has Competition From Lokelma

 
• By Kevin Grogan
  
Two_Road_Bikers
Vifor looks to maintain its lead over AstraZeneca in hyperkalemia market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Blood and Clotting

More from Therapy Areas